The global Tacrolimus API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tacrolimus API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tacrolimus API.
Report Scope
The Tacrolimus API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tacrolimus API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tacrolimus API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hangzhou Zhongmei Huadong Pharmaceutical
Guangzhou Tosun Pharmaceutical
Chunghwa Chemical Synthesis & Biotech
ChemWerth Inc
Dr. Reddy's Laboratories
Zeon Health Industries
Fishfa Biogenics
Teva API
Apotex Fermentation Inc.
Astellas Pharma
Bills Biotech
CKD Bio Corporation
Concord Biotech
JOYANG LABORATORIES
Lek Pharmaceuticals
Murli Krishna Pharma
Viruj Pharmaceuticals Pvt. Ltd
Zhejiang Hisun Pharmaceutical
Segment by Type
0.98
0.99
Others
Segment by Application
Capsules
Injection
Ointments
Eye Drops
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tacrolimus API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tacrolimus API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tacrolimus API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Tacrolimus API Market Overview
1.1 Product Definition
1.2 Tacrolimus API Segment by Type
1.2.1 Global Tacrolimus API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Tacrolimus API Segment by Application
1.3.1 Global Tacrolimus API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Capsules
1.3.3 Injection
1.3.4 Ointments
1.3.5 Eye Drops
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Tacrolimus API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Tacrolimus API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Tacrolimus API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Tacrolimus API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tacrolimus API Production Market Share by Manufacturers (2019-2024)
2.2 Global Tacrolimus API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Tacrolimus API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Tacrolimus API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Tacrolimus API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Tacrolimus API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tacrolimus API, Product Offered and Application
2.8 Global Key Manufacturers of Tacrolimus API, Date of Enter into This Industry
2.9 Tacrolimus API Market Competitive Situation and Trends
2.9.1 Tacrolimus API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tacrolimus API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tacrolimus API Production by Region
3.1 Global Tacrolimus API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Tacrolimus API Production Value by Region (2019-2030)
3.2.1 Global Tacrolimus API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Tacrolimus API by Region (2025-2030)
3.3 Global Tacrolimus API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Tacrolimus API Production by Region (2019-2030)
3.4.1 Global Tacrolimus API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Tacrolimus API by Region (2025-2030)
3.5 Global Tacrolimus API Market Price Analysis by Region (2019-2024)
3.6 Global Tacrolimus API Production and Value, Year-over-Year Growth
3.6.1 North America Tacrolimus API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Tacrolimus API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Tacrolimus API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Tacrolimus API Production Value Estimates and Forecasts (2019-2030)
4 Tacrolimus API Consumption by Region
4.1 Global Tacrolimus API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Tacrolimus API Consumption by Region (2019-2030)
4.2.1 Global Tacrolimus API Consumption by Region (2019-2024)
4.2.2 Global Tacrolimus API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Tacrolimus API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Tacrolimus API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tacrolimus API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Tacrolimus API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tacrolimus API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Tacrolimus API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tacrolimus API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Tacrolimus API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Tacrolimus API Production by Type (2019-2030)
5.1.1 Global Tacrolimus API Production by Type (2019-2024)
5.1.2 Global Tacrolimus API Production by Type (2025-2030)
5.1.3 Global Tacrolimus API Production Market Share by Type (2019-2030)
5.2 Global Tacrolimus API Production Value by Type (2019-2030)
5.2.1 Global Tacrolimus API Production Value by Type (2019-2024)
5.2.2 Global Tacrolimus API Production Value by Type (2025-2030)
5.2.3 Global Tacrolimus API Production Value Market Share by Type (2019-2030)
5.3 Global Tacrolimus API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Tacrolimus API Production by Application (2019-2030)
6.1.1 Global Tacrolimus API Production by Application (2019-2024)
6.1.2 Global Tacrolimus API Production by Application (2025-2030)
6.1.3 Global Tacrolimus API Production Market Share by Application (2019-2030)
6.2 Global Tacrolimus API Production Value by Application (2019-2030)
6.2.1 Global Tacrolimus API Production Value by Application (2019-2024)
6.2.2 Global Tacrolimus API Production Value by Application (2025-2030)
6.2.3 Global Tacrolimus API Production Value Market Share by Application (2019-2030)
6.3 Global Tacrolimus API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Hangzhou Zhongmei Huadong Pharmaceutical
7.1.1 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Corporation Information
7.1.2 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Product Portfolio
7.1.3 Hangzhou Zhongmei Huadong Pharmaceutical Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business and Markets Served
7.1.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments/Updates
7.2 Guangzhou Tosun Pharmaceutical
7.2.1 Guangzhou Tosun Pharmaceutical Tacrolimus API Corporation Information
7.2.2 Guangzhou Tosun Pharmaceutical Tacrolimus API Product Portfolio
7.2.3 Guangzhou Tosun Pharmaceutical Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.2.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
7.3 Chunghwa Chemical Synthesis & Biotech
7.3.1 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Corporation Information
7.3.2 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Product Portfolio
7.3.3 Chunghwa Chemical Synthesis & Biotech Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Chunghwa Chemical Synthesis & Biotech Main Business and Markets Served
7.3.5 Chunghwa Chemical Synthesis & Biotech Recent Developments/Updates
7.4 ChemWerth Inc
7.4.1 ChemWerth Inc Tacrolimus API Corporation Information
7.4.2 ChemWerth Inc Tacrolimus API Product Portfolio
7.4.3 ChemWerth Inc Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 ChemWerth Inc Main Business and Markets Served
7.4.5 ChemWerth Inc Recent Developments/Updates
7.5 Dr. Reddy's Laboratories
7.5.1 Dr. Reddy's Laboratories Tacrolimus API Corporation Information
7.5.2 Dr. Reddy's Laboratories Tacrolimus API Product Portfolio
7.5.3 Dr. Reddy's Laboratories Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.6 Zeon Health Industries
7.6.1 Zeon Health Industries Tacrolimus API Corporation Information
7.6.2 Zeon Health Industries Tacrolimus API Product Portfolio
7.6.3 Zeon Health Industries Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Zeon Health Industries Main Business and Markets Served
7.6.5 Zeon Health Industries Recent Developments/Updates
7.7 Fishfa Biogenics
7.7.1 Fishfa Biogenics Tacrolimus API Corporation Information
7.7.2 Fishfa Biogenics Tacrolimus API Product Portfolio
7.7.3 Fishfa Biogenics Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Fishfa Biogenics Main Business and Markets Served
7.7.5 Fishfa Biogenics Recent Developments/Updates
7.8 Teva API
7.8.1 Teva API Tacrolimus API Corporation Information
7.8.2 Teva API Tacrolimus API Product Portfolio
7.8.3 Teva API Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Teva API Main Business and Markets Served
7.7.5 Teva API Recent Developments/Updates
7.9 Apotex Fermentation Inc.
7.9.1 Apotex Fermentation Inc. Tacrolimus API Corporation Information
7.9.2 Apotex Fermentation Inc. Tacrolimus API Product Portfolio
7.9.3 Apotex Fermentation Inc. Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Apotex Fermentation Inc. Main Business and Markets Served
7.9.5 Apotex Fermentation Inc. Recent Developments/Updates
7.10 Astellas Pharma
7.10.1 Astellas Pharma Tacrolimus API Corporation Information
7.10.2 Astellas Pharma Tacrolimus API Product Portfolio
7.10.3 Astellas Pharma Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Astellas Pharma Main Business and Markets Served
7.10.5 Astellas Pharma Recent Developments/Updates
7.11 Bills Biotech
7.11.1 Bills Biotech Tacrolimus API Corporation Information
7.11.2 Bills Biotech Tacrolimus API Product Portfolio
7.11.3 Bills Biotech Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Bills Biotech Main Business and Markets Served
7.11.5 Bills Biotech Recent Developments/Updates
7.12 CKD Bio Corporation
7.12.1 CKD Bio Corporation Tacrolimus API Corporation Information
7.12.2 CKD Bio Corporation Tacrolimus API Product Portfolio
7.12.3 CKD Bio Corporation Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 CKD Bio Corporation Main Business and Markets Served
7.12.5 CKD Bio Corporation Recent Developments/Updates
7.13 Concord Biotech
7.13.1 Concord Biotech Tacrolimus API Corporation Information
7.13.2 Concord Biotech Tacrolimus API Product Portfolio
7.13.3 Concord Biotech Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Concord Biotech Main Business and Markets Served
7.13.5 Concord Biotech Recent Developments/Updates
7.14 JOYANG LABORATORIES
7.14.1 JOYANG LABORATORIES Tacrolimus API Corporation Information
7.14.2 JOYANG LABORATORIES Tacrolimus API Product Portfolio
7.14.3 JOYANG LABORATORIES Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 JOYANG LABORATORIES Main Business and Markets Served
7.14.5 JOYANG LABORATORIES Recent Developments/Updates
7.15 Lek Pharmaceuticals
7.15.1 Lek Pharmaceuticals Tacrolimus API Corporation Information
7.15.2 Lek Pharmaceuticals Tacrolimus API Product Portfolio
7.15.3 Lek Pharmaceuticals Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Lek Pharmaceuticals Main Business and Markets Served
7.15.5 Lek Pharmaceuticals Recent Developments/Updates
7.16 Murli Krishna Pharma
7.16.1 Murli Krishna Pharma Tacrolimus API Corporation Information
7.16.2 Murli Krishna Pharma Tacrolimus API Product Portfolio
7.16.3 Murli Krishna Pharma Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Murli Krishna Pharma Main Business and Markets Served
7.16.5 Murli Krishna Pharma Recent Developments/Updates
7.17 Viruj Pharmaceuticals Pvt. Ltd
7.17.1 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Corporation Information
7.17.2 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Product Portfolio
7.17.3 Viruj Pharmaceuticals Pvt. Ltd Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Viruj Pharmaceuticals Pvt. Ltd Main Business and Markets Served
7.17.5 Viruj Pharmaceuticals Pvt. Ltd Recent Developments/Updates
7.18 Zhejiang Hisun Pharmaceutical
7.18.1 Zhejiang Hisun Pharmaceutical Tacrolimus API Corporation Information
7.18.2 Zhejiang Hisun Pharmaceutical Tacrolimus API Product Portfolio
7.18.3 Zhejiang Hisun Pharmaceutical Tacrolimus API Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Zhejiang Hisun Pharmaceutical Main Business and Markets Served
7.18.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tacrolimus API Industry Chain Analysis
8.2 Tacrolimus API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tacrolimus API Production Mode & Process
8.4 Tacrolimus API Sales and Marketing
8.4.1 Tacrolimus API Sales Channels
8.4.2 Tacrolimus API Distributors
8.5 Tacrolimus API Customers
9 Tacrolimus API Market Dynamics
9.1 Tacrolimus API Industry Trends
9.2 Tacrolimus API Market Drivers
9.3 Tacrolimus API Market Challenges
9.4 Tacrolimus API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Hangzhou Zhongmei Huadong Pharmaceutical
Guangzhou Tosun Pharmaceutical
Chunghwa Chemical Synthesis & Biotech
ChemWerth Inc
Dr. Reddy's Laboratories
Zeon Health Industries
Fishfa Biogenics
Teva API
Apotex Fermentation Inc.
Astellas Pharma
Bills Biotech
CKD Bio Corporation
Concord Biotech
JOYANG LABORATORIES
Lek Pharmaceuticals
Murli Krishna Pharma
Viruj Pharmaceuticals Pvt. Ltd
Zhejiang Hisun Pharmaceutical
听
听
*If Applicable.
